Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Total revenue | 0.88%7.39M | 1,054.57%7.32M | -68.51%634.42K | 212.86%2.01M | 123.21%644K | 288.52K |
| Operating revenue | 0.88%7.39M | 1,054.57%7.32M | -68.51%634.42K | 212.86%2.01M | 123.21%644K | --288.52K |
| Cost of revenue | -14.58%2.34M | 730.02%2.74M | -77.70%329.69K | 314.18%1.48M | 415.49%357K | 69.25K |
| Gross profit | 10.10%5.05M | 1,405.70%4.59M | -43.17%304.74K | 86.83%536.2K | 30.89%287K | 219.26K |
| Operating expense | 45.03%12.93M | 49.32%8.91M | -1.21%5.97M | -5.63%6.04M | 70.31%6.4M | 3.76M |
| Selling and administrative expenses | 45.01%7.86M | 107.86%5.42M | 26.12%2.61M | -40.53%2.07M | 75.24%3.48M | --1.98M |
| -Selling and marketing expense | --234.51K | ---- | -72.80%40.31K | -9.09%148.18K | --163K | ---- |
| -General and administrative expense | 40.68%7.62M | 111.12%5.42M | 33.76%2.57M | -42.08%1.92M | 67.02%3.31M | --1.98M |
| Research and development costs | 83.37%1.06M | -20.64%578.94K | -53.22%729.52K | 114.23%1.56M | --728K | ---- |
| Depreciation amortization depletion | 13.54%934.39K | 19.51%822.95K | -4.51%688.59K | 76.31%721.12K | 376.53%409K | --85.83K |
| -Depreciation and amortization | 13.54%934.39K | 19.51%822.95K | -4.51%688.59K | 76.31%721.12K | 376.53%409K | --85.83K |
| Other operating expenses | 46.86%3.08M | 7.65%2.09M | 14.72%1.95M | -5.33%1.7M | 5.93%1.79M | --1.69M |
| Operating profit | -82.08%-7.88M | 23.64%-4.33M | -2.88%-5.67M | 9.97%-5.51M | -72.75%-6.12M | -3.54M |
| Net non-operating interest income (expenses) | 298.88%74.16K | -182.14%-37.29K | 363.81%45.39K | -960.35%-17.21K | -83.02%2K | 11.78K |
| Non-operating interest income | 424.54%259.65K | -23.73%49.5K | 830.90%64.9K | -65.14%6.97K | 69.78%20K | --11.78K |
| Non-operating interest expense | 113.73%185.5K | 344.89%86.79K | -19.32%19.51K | 34.33%24.18K | --18K | ---- |
| Other net income (expenses) | 107.08%401.54K | 5.38%193.91K | -70.67%184.01K | 4.56%627.39K | 37.91%600K | 435.05K |
| Special income (charges) | -232.99%-13.57K | 82.56%10.2K | -85.24%5.59K | --37.87K | ---- | ---- |
| -Gain on sale of property,plant,equipment | -232.99%-13.57K | 82.56%10.2K | -85.24%5.59K | --37.87K | ---- | ---- |
| Other non-operating income (expenses) | 125.97%415.11K | 2.96%183.7K | -69.73%178.42K | -1.75%589.52K | 37.91%600K | --435.05K |
| Income before tax | -77.51%-7.4M | 23.30%-4.17M | -11.01%-5.44M | 11.21%-4.9M | -78.25%-5.52M | -3.09M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||
| Net income | -77.51%-7.4M | 23.30%-4.17M | -11.01%-5.44M | 11.21%-4.9M | -78.25%-5.52M | -3.09M |
| Net income continuous operations | -77.51%-7.4M | 23.30%-4.17M | -11.01%-5.44M | 11.21%-4.9M | -78.25%-5.52M | ---3.09M |
| Noncontrolling interests | ||||||
| Net income attributable to the company | -77.51%-7.4M | 23.30%-4.17M | -11.01%-5.44M | 11.21%-4.9M | -78.25%-5.52M | -3.09M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | ||||||
| Net income attributable to common stockholders | -77.51%-7.4M | 23.30%-4.17M | -11.01%-5.44M | 11.21%-4.9M | -78.25%-5.52M | -3.09M |
| Diluted earnings per share | 5.88%-0.016 | 35.85%-0.017 | 18.18%-0.0265 | 13.16%-0.0324 | 0.00%-0.0373 | -0.0373 |
| Basic earnings per share | 5.88%-0.016 | 35.85%-0.017 | 18.18%-0.0265 | 13.16%-0.0324 | 0.00%-0.0373 | -0.0373 |
| Dividend per share | ||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |